Provider
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™ - Opens in a new window
Program effective Date: Jul 12, 2023
Documents & Forms Results
Displaying 1601 - 1610 of 3114 results
Provider
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™ - Opens in a new window
Program effective Date: Jul 12, 2023
Provider
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023 - Opens in a new window
Program effective Date: Jul 12, 2023
Provider
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023 - Opens in a new window
Program effective Date: Jul 12, 2023
Provider
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox) - Opens in a new window
Program effective Date: Jul 12, 2023
Provider
P47R1-23 MHCP Enrollment for Managed Care Organization (MCO) In-network Only Providers - Opens in a new window
Program effective Date: Jul 03, 2023
Provider
P48-23 Additional Records Received After Due Date - Opens in a new window
Program effective Date: Jul 03, 2023
Provider
P49-23 Minnesota Health Care Programs (MHCP) Operations Transition: New ID Numbers for MHCP Members - Opens in a new window
Program effective Date: Jul 03, 2023
Provider
P50-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates - Opens in a new window
Program effective Date: Jul 03, 2023
Provider
2023 July Bulletins - Opens in a new window
Program effective Date: Jul 03, 2023